Development of small molecule inhibitors of RBM46 as novel male contraceptives

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Hermann Brian

Funded by

Natl Inst of Health

Research Start Date

12/01/2023

Status

Active

Applied Research

Collaborative Project

Basic Research

Drug Discovery

Regenerative Medicine

Bioscience Research Panel